HALOZYME THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Halozyme Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Halozyme Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 24, 2024 was 127M shares, a 3.69% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 127M -4.87M -3.69% Oct 24, 2024 10-Q 2024-10-31
Q2 2024 127M -5.24M -3.97% Jul 31, 2024 10-Q 2024-08-06
Q1 2024 127M -4.41M -3.35% Apr 30, 2024 10-Q 2024-05-07
Q4 2023 127M -8.54M -6.31% Feb 12, 2024 10-K 2024-02-20
Q3 2023 132M -3.11M -2.3% Oct 31, 2023 10-Q 2023-11-06
Q2 2023 132M -5.86M -4.25% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 132M -6.27M -4.55% Apr 28, 2023 10-Q 2023-05-09
Q4 2022 135M -2.34M -1.7% Feb 14, 2023 10-K 2023-02-21
Q3 2022 135M -5.57M -3.96% Oct 31, 2022 10-Q 2022-11-08
Q2 2022 138M -4.56M -3.2% Aug 2, 2022 10-Q 2022-08-09
Q1 2022 138M -4.44M -3.12% May 4, 2022 10-Q 2022-05-10
Q4 2021 138M Feb 14, 2022 10-K 2022-02-22
Q3 2021 141M +5.6M +4.15% Oct 25, 2021 10-Q 2021-11-02
Q2 2021 142M +5.31M +3.87% Aug 3, 2021 10-Q 2021-08-09
Q1 2021 142M +6.57M +4.84% May 5, 2021 10-Q 2021-05-10
Q3 2020 135M -11.4M -7.75% Oct 28, 2020 10-Q 2020-11-02
Q2 2020 137M -9.28M -6.35% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 136M -9.69M -6.66% May 6, 2020 10-Q 2020-05-11
Q4 2019 138M -6.81M -4.69% Feb 14, 2020 10-K 2020-02-24
Q3 2019 147M +1.98M +1.37% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 146M +2.01M +1.39% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 146M +1.54M +1.07% Apr 30, 2019 10-Q 2019-05-07
Q4 2018 145M +1.96M +1.37% Feb 14, 2019 10-K 2019-02-21
Q3 2018 145M +2.2M +1.55% Oct 30, 2018 10-Q 2018-11-06
Q2 2018 144M +2.39M +1.68% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 144M +14.1M +10.9% May 3, 2018 10-Q 2018-05-10
Q4 2017 143M Feb 13, 2018 10-K 2018-02-20
Q3 2017 142M +12.9M +9.94% Nov 1, 2017 10-Q 2017-11-07
Q2 2017 142M +12.5M +9.66% Aug 1, 2017 10-Q 2017-08-08
Q1 2017 130M +700K +0.54% May 1, 2017 10-Q 2017-05-09
Q3 2016 129M +1.48M +1.15% Nov 1, 2016 10-Q 2016-11-07
Q2 2016 129M +117M +913% Aug 2, 2016 10-Q 2016-08-09
Q1 2016 129M +2.44M +1.92% May 2, 2016 10-Q 2016-05-09
Q3 2015 128M +2.63M +2.1% Nov 2, 2015 10-Q 2015-11-09
Q2 2015 12.8M -113M -89.8% Aug 6, 2015 10-Q 2015-08-10
Q1 2015 127M +2.2M +1.76% Feb 24, 2015 10-K 2015-03-02
Q3 2014 125M +11.4M +9.96% Nov 5, 2014 10-Q 2014-11-10
Q2 2014 125M +12M +10.6% Aug 5, 2014 10-Q 2014-08-11
Q1 2014 125M +11.4M +10.1% May 5, 2014 10-Q 2014-05-12
Q3 2013 114M +1.32M +1.17% Nov 4, 2013 10-Q 2013-11-08
Q2 2013 113M +593K +0.53% Aug 5, 2013 10-Q 2013-08-07
Q1 2013 113M +680K +0.6% Feb 25, 2013 10-K 2013-03-01
Q3 2012 113M +9.01M +8.69% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 113M +9.07M +8.76% Aug 1, 2012 10-Q 2012-08-09
Q1 2012 112M Apr 30, 2012 10-Q 2012-05-07
Q3 2011 104M Nov 2, 2011 10-Q 2011-11-08
Q2 2011 104M Aug 1, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.